Applied DNA Sciences, Inc. (APDN) Financials

APDN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 9.9 million 2.9 million
March 31, 2025 13.0 million 2.8 million
Dec. 31, 2024 16.0 million 3.4 million
Sept. 30, 2024 12.8 million 3.8 million

APDN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -2.8 million 24889
March 31, 2025 -3.4 million 26511
Dec. 31, 2024 -3.4 million 28973
Sept. 30, 2024 -3.6 million 30248

APDN Net Income

No data available :(

APDN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 4.7 million - 334403
March 31, 2025 6.8 million - 472390
Dec. 31, 2024 9.3 million 97722 607287
Sept. 30, 2024 6.4 million 386498 739161

APDN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 572018
March 31, 2025 1.8 million
Dec. 31, 2024 31.5 million
Sept. 30, 2024 17.7 million

APDN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 10923 768563 2.9 million -
March 31, 2025 185319 849358 3.0 million -
Dec. 31, 2024 116879 1.0 million 2.6 million -
Sept. 30, 2024 371250 831710 2.7 million -

APDN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 304393 299263
March 31, 2025 983374 612527
Dec. 31, 2024 1.2 million 512510
Sept. 30, 2024 813107 568208

APDN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

APDN

Price: $4.27

52 week price:
2.13
330.00

Payout Ratio Range:
-142.62%
-0.07%

Earnings Per Share: -57.12 USD

P/E Ratio: -0.07

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 276529

Ebitda: -5.5 million

Market Capitalization: 2.2 million

Links: